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ABSTRAK 
 
PENGENALAN 
Madu dikenali sebagai rawatan alternatif untuk pelbagai jenis penyakit. Ubat titis mata 
antibakteria madu Manuka telah dipasarkan untuk penyakit jangkitan mata. Kami berhasrat 
untuk meneroka potensi madu Tualang untuk dikomersialkan dalam penggunaan oftalmologi. 
Oleh itu, kami telah menjalankan satu kajian eksperimen untuk membandingkan kesan 
klinikal dan antibakteria madu Tualang dan Manuka sebagai rawatan tambahan dalam 
Pseudomonas keratitis. 
 
OBJEKTIF 
Beberapa kajian in-vitro telah menunjukkan bahawa madu Tualang dan Manuka mempunyai 
kesan antibakteria terhadap Pseudomonas aeruginosa. Kajian ini dilakukan untuk 
membandingkan min skor Slit Lamp Examination (SLE) dan min kiraan Colony Forming 
Unit (CFU) atas Pseudomonas keratitis pada mata arnab. 
 
KAEDAH KAJIAN 
Kajian eksperimen haiwan ini terdiri daripada 20 ekor arnab yang dijangkiti dengan 
Pseudomonas keratitis dan dibahagikan secara rawak dan sama rata kepada dua kumpulan. 
Kumpulan A telah dirawat dengan gabungan madu Tualang 30% dan gentamicin 0.3% lapan 
kali sehari, manakala kumpulan B telah dirawat dengan gabungan madu Manuka dan 
gentamicin 0.3% lapan kali setiap hari. Pada masa yang sama, satu kajian selari dengan 
kaedah yang sama telah dijalankan ke atas sepuluh ekor arnab yang telah dirawat dengan 
gentamicin 0.3% sebagai kumpulan kawalan. Pemeriksaan klinikal secara bersiri 
menggunakan skor SLE telah dilakukan pada 24, 48, 72 jam, hari ke-5 dan hari ke-7. Semua 
vii 
 
arnab telah dieutanasia pada hari ke-7 dan kornea mereka dituai. Kornea dituai telah diproses 
dan kiraan CFU telah dilakukan pada hari berikutnya. „Repeated measure ANOVA’ dan 
„Mann-Whitney’ telah digunakan untuk data analisis. 
 
KEPUTUSAN 
Tiada perbezaan yang ketara secara statistik untuk hasil klinikal (p = 0.434) dan kesan anti-
bakteria (p = 0.198) antara madu Tualang dan madu Manuka sebagai rawatan tambahan 
dalam Pseudomonas keratitis. 
 
KESIMPULAN 
Madu Tualang adalah setanding dengan madu Manuka sebagai rawatan tambahan dalam 
Pseudomonas keratitis pada mata arnab. 
 
KATA KUNCI 
Pseudomonas keratitis, madu Tualang, madu Manuka, kesan klinikal, kesan antibakteria 
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ABSTRACT 
 
INTRODUCTION 
Honey is a known alternative therapy for varies diseases. Manuka honey antibacterial eye 
drop is established marketed honey for eye infection. We aim to explore the potential of 
Tualang honey to be commercialized in ophthalmic usage. Thus, we conducted an 
experimental study to compare the clinical and antibacterial effects of Tualang and Manuka 
honey as adjunctive treatment in Pseudomonas keratitis.   
 
OBJECTIVE 
Several in vitro studies documented that Tualang and Manuka honey had antibacterial effect 
towards Pseudomonas aeruginosa. This study is done to compare the mean Slit Lamp 
Examination (SLE) score and mean Colony Forming Unit (CFU) count of Pseudomonas-
induced keratitis in rabbit eyes.  
 
METHODS 
This experimental animal study consisted of 20 rabbits induced with Pseudomonas keratitis 
that were randomly and equally divided into two groups. Group A was treated with a 
combination of Tualang honey 30% and gentamycin 0.3% eight times per day, while Group 
B was treated with a combination of Manuka honey and gentamycin 0.3% eight times per 
day. At the same time, a parallel study with similar methodology was conducted on ten 
rabbits which were treated with gentamycin 0.3% as a control group. Serial clinical 
examination using Slit Lamp Examination (SLE) score was done at 24, 48, 72 hours, Day 5 
and Day 7. All rabbits were euthanized at Day 7 and their corneas harvested. The harvested 
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corneas were processed and Colony Forming Unit (CFU) counts were performed on the next 
day. Repeated measure ANOVA and Mann-Whitney test were used for the data analysis.  
 
RESULTS 
There was no statistically significant difference of clinical outcome (p=0.434) and 
antibacterial effect (p=0.198) between Tualang honey and Manuka honey as adjunctive 
treatment in Pseudomonas keratitis.  
 
CONCLUSION 
Tualang honey is comparable to Manuka honey as adjunctive treatment in Pseudomonas 
keratitis in rabbit eyes. 
 
KEYWORDS 
Pseudomonas keratitis, Tualang honey, Manuka Honey, Clinical effect, Antibacterial effect  
x 
 
 
 1 
 
 
 
 
 
 
 
 
 
 
CHAPTER 1:  
INTRODUCTION 
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Pseudomonas keratitis is a common complication of contact lens and vegetative ocular injury 
(Hooi et al., 2005; Norina et al., 2008; Willcox., 2012). Rapid corneal perforation occurs due 
to a combination of Pseudomonas aeruginosa’s protease enzymes and an intense host 
immune inflammatory reaction (Kessler et al., 1977). Therefore, urgent and prompt treatment 
is needed in order to minimize this devastating ocular complication. 
 
A study by Faiz et al. (2007) has shown that only 33% of Pseudomonas keratitis is sensitive 
towards gentamycin. Similarly, a report by Bharati et al. (2010) documented that gentamycin 
only effective towards 55% of Pseudomonas keratitis patients. Therefore, this indicates an 
alarming phenomenon regarding resistance of antibiotic in the treatment of Pseudomonas 
keratitis.  
 
Apitheraphy is an alternative medicine that uses bee products especially honey. The unique 
properties are determined by the bee‟s floral and geographical area of origin (Taormina et al., 
2001). Honey has been proven to have antibacterial, healing properties, anti-inflammatory 
anticarcinogenic, and antifungal (Dustman., 1979; Sadagatullah et al., 2011; Bashkaran et al., 
2011; Kadir et al., 2013; Sayadi et al., 2015).    
 
Tualang honey is a local Malaysian honey while Manuka honey is a well commercialized 
honey from Australia and New Zealand. Tualang honey is a multifloral honey with higher 
phenolics, flavonoids and 5-hydroxymethyl-furfural than Manuka honey (Sarfarz et al., 
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2013). Meanwhile, Manuka honey is a monofloral honey with its antibacterial properties 
derived from high non hydrogen peroxide and methylglyoxal activity (Khan et al., 2007). 
In vitro study by Tan et al. (2009) demonstrated that Tualang and Manuka honey have similar 
level of Minimum Inhibitory Concentration against Pseudomonas aeruginosa. In fact, 
Sadagatullah et al. (2011) proved that the wound healing properties of Tualang honey are 
comparable to Manuka honey in post debridement diabetic foot wounds.  
 
Manuka honey has been well established medical honey in many fields including 
ophthalmology. Malhotra et al. (2016) showed that Manuka honey has healing effect towards 
bilateral upper blepharoplasty scar. On the other hand, Albietz et al. (2015) demonstrated that 
Manuka honey was a safe and effective adjunctive therapy for persistent post-operative 
corneal oedema.  
 
To date, there is limited data available on the use of Tualang honey in ophthalmology 
practice. Recently, Bashkaran et al. (2011) reported that Tualang honey has corneal healing 
effect in experimental alkaline corneal injury in rabbits. However, we have not encountered 
literature comparing the clinical and antibacterial effect of Manuka and Tualang honey as 
adjunctive treatment in Pseudomonas keratitis.  
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2.1 INTRODUCTION 
 
2.1.1 Pseudomonas Keratitis 
 
Corneal ulcer and keratitits cause by Pseudomonas aeruginosa is a common type of contact 
lens related ulcer (Choy et al., 2008). Most of the patients are young and healthy. It is known 
to cause rapid cornea perforation due to collagenase activity of the Pseudomonas. Urgent and 
intensive treatment is needed to prevent this vision threatening event. In practice, topical 
gentamycin and flouroquinolone are proven as standard treatment (Willcox., 2012). However, 
the issue on antibiotic resistance in treatment of keratitis is on the rise. The antibiotic 
resistance in ocular infection is contributed by prolonged and overuse therapy (Sharma.,  
2011). 
 
2.1.2 Honey 
 
Recently, modern medical therapy is developing their new treatment from natural source of 
product such as honey as it is cost effective and unlikely to develop resistance and side 
effects. Honey is a natural product of bees. The antibacterial activity of honey was first 
recognized in 1892 (Dustmann., 1979).  Honey can inhibit the growth of bacteria, fungal and 
protozoa (Molan., 1992). The difference of its properties is determined by different floral and 
geographical area of origin of the bees (Taormina et al., 2001). Many studies were conducted 
to prove its anti-inflammatory, healing properties, antibacterial, antioxidant, anticarcinogenic 
and antifungal (Molan., 1992; Medhi et al., 2008; Tan et al., 2009; Bashkaran et al., 2011; 
Kadir et al., 2013; Sayadi et al., 2015). The successful of honey in treatment of surgical 
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(Bansal et al., 2005) and diabetic wound healing (Makhdoom et al., 2009) encourage the 
initiatives to prove its effectiveness in other field including ophthalmology. 
 
2.1.3 Tualang and Manuka honey 
 
Tualang honey is a Malaysian honey derived from Koompassia excelsa (Tualang tree). It is a 
natural honey that is comparable to other types of honey. Properties that contribute to its 
beneficial effects are from the non-enzymetic and enzymetic activities. It is rich in protein 
especially proline, vitamins, minerals, flavonoid and alkaloid. Enzymetic properties are 
hydrogen peroxide, oxidase, invertase, catalase, and amylase (Molan., 1992). Brudzynski 
(2006) reported that dilution of honey enhances its antibacterial activity due to hydrogen 
peroxide enzyme. 
 
Tumin et al. (2005) have conducted a study regarding antibacterial properties of different 
types of honey in Malaysia. Tualang honey is the most acidic local honey with pH 3.55. 
Acidity contributes for the antibacterial activity. They reported that Tualang honey has the 
lowest Minimum Inhibitory Concentration (MIC) of 48.75µg/ml for Pseudomonas 
aeruginosa compared to other local type of honey 57.50 µg/ml, 70 µg/ml, 80 µg/ml and 135 
µg/ml respectively for Hutan, Gelang, Pucuk daun and Ee Feng Gu.  
 
Manuka honey is an Australian and New Zealand honey that has been proven to be effective 
in treating many types of disease by many studies. Manuka honey demonstrates both 
peroxide and non peroxide activity (Molan., 1992). Thus, this suggests its antibacterial 
activity will still be effective in the absence of hydrogen peroxide enzyme.  
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Research has been done for Tualang and Manuka honey to compare their ability in treating 
infected wound and healing process (Sadagatullah et al., 2011; Sarfarz et al., 2013). The 
comparison between these honeys in ophthalmology practise is still lacking.    
 
 
2.2 RESEARCH OBJECTIVE 
 
2.2.1 General Objective 
 
To evaluate the clinical response and antibacterial effects of Tualang honey and Manuka 
honey as adjunctive treatment in Pseudomonas-induced keratitis in rabbit eyes. 
 
2.2.2 Specific Objectives 
 
i. To compare the mean Slit Lamp Examination (SLE) score between Tualang honey 
and Manuka honey as adjunctive treatment in Pseudomonas-induced keratitis at 24, 
48, 72 hours, 5th and 7th day. 
ii. To compare the mean Colony Forming Unit (CFU) count of Pseudomonas-induced 
keratitis following treatment of Tualang honey and Manuka honey at Day 7.  
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2.3 RESEARCH HYPOTHESIS 
 
1. There is a significance difference in the SLE score of Pseudomonas-induced 
keratitis in rabbit eyes between Tualang honey and Manuka honey as adjunctive 
treatment. 
2. There is a significance difference in CFU count of Pseudomonas aeruginosa 
between Tualang honey and Manuka honey as adjunctive treatment. 
 
 2.4 DEFINITION OF TERMS 
 
 2.4.1 Tualang honey 
 
Tualang honey is obtained from Federal Agriculture Marketing Authority (FAMA), 
Kedah Malaysia which was collected from Koompassia excelsa (Tualang tree). 
 
 2.4.2 Manuka honey 
 
Manuka honey is an Australian or New Zealand‟s honey that commercially available 
in viscous eye drop manufactured by Melcare Biomedical Pty Ltd. Each sterilized    
tube contains 98% Leptospermum scoparium. 
 
2.4.3 Clinical response 
 
Clinical response is examination of rabbit‟s eye using a portable slit lamp based on 
SLE score system (Dong et al., 2012).  
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2.4.4 Colony forming unit 
 
Calculation of viable Pseudomonas aeruginosa in rabbits harvested corneas post 
treatment.   
 
2.5 METHODOLOGY 
 
2.5.1 Study Design 
Randomized control trial 
 
 
2.5.2 Study Location 
 
Animal Research and Study Centre (ARASC), Microbiology and Parasitology 
laboratory, Universiti Sains Malaysia, Health Campus, Kubang Kerian 
 
2.5.3 Study Duration 
 
September 2014 - August 2016 
 
2.5.4 Study population 
 
New Zealand white adult rabbits will be obtained from ARASC, Universiti Sains 
Malaysia, Health Campus, Kubang Kerian. 
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2.5.5 Sampling Method 
 
Randomization of 20 New Zealand white adult rabbits (aged 8 - 10 months, weighing 
between 2.0 and 2.5kg) into 2 groups (A and B) consisting of 10 rabbits in each 
group. 
 
2.5.6 Inclusion & Exclusion Criteria 
 
Inclusion Criteria 
1. All healthy adult rabbits with clear corneas that are successfully 
induced with Pseudomonas keratitis. 
Exclusion Criteria 
1. Rabbits with cornea perforation. 
2. Rabbits with systemic infection of Pseudomonas aeruginosa. 
 
2.5.7 Determination of Sample Size 
 
Sample Size Calculation 
Objective 1: To compare the mean SLE score between Tualang honey and 
Manuka honey as adjunctive treatment in Pseudomonas-induced keratitis at 
24, 48, 72 hours, 5th and 7th day. 
  Effect size = 0.4, Power = 80%, Alpha level = 5% (0.05) 
Number of group = 2, Number of evaluation = 5  
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Calculated sample size is 10 rabbits per group 
 
Objective 2: To compare the mean CFU count of Pseudomonas-induced 
keratitis following treatment of Tualang honey and Manuka honey at Day 7. 
 Effect size = 0.4, Power = 80 %, Alpha level = 5% (0.05)  
Number of group = 2 
Calculated sample size is 52 rabbits per group  
  
The sample size is chosen based on first objective as the numbers of the 
rabbits are smaller 
 
Calculated sample size is 10 rabbits per group 
30% dropout rate = 7 
Total number of rabbits needed = (10 x 2) + 7 = 27 
 
2.5.8 Randomization Method  
 
Twenty New Zealand white adult rabbits (aged 8 - 10 months) weighing 
between 2.0 and 2.5kg will be used in this study. The rabbits will be randomly 
divided into 2 groups (A and B) consisting of 10 rabbits in each group.  
 
a) Group A will be treated with a combination of one drop of topical Tualang 
honey 30% and one drop of topical gentamycin 0.3%.  
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b) Group B will be treated with a combination of one drop of topical Manuka 
honey and one drop of topical gentamycin 0.3%.  
 
2.5.9 Research Tools 
 
A. Animals 
1. New Zealand white adult rabbits 
2. Rabbit cage  
3. Pellet and bedding      
B. Drugs and Solutions 
1. Ketamine hydrochloride (Troy Laboratories, New South 
Wales, Australia) 
2. Xylazine hydrochloride (Troy Laboratories, New South 
Wales, Australia) 
3. Pentobarbital sodium (Troy Laboratories, New South 
Wales, Australia) 
4. Buphrenorphine (Troy Laboratories, New South Wales, 
Australia) 
5. Proparacaine hydrochloride 0.5% eye drops (Alcon-
Couvreur Puurs, Belgium) 
6. Gentamycin 0.3% eye drops (FDC Ltd)  
7. Topical Tualang honey 30% (FAMA) 
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8. Topical Manuka honey (Melcare Biomedical Pty Ltd, 
Australia)  
9. Trypticase Soy broth and agar plates (Thermo Scientific 
Microbiology Sdn. Bhd)      
10. 1% fluorescein strip (Chauvin Pharmaceuticals Ltd, 
England) 
11. Povidone iodine 
C. Ophthalmic instrument for routine clinical examination 
1. Portable slit lamp (Kowa SL-15) 
D. Surgical instruments 
1. Needles 27G and 30G 
2. Syringes 1ml and 5ml 
3. Dressing set 
4. Caliper 
5. Barraquer wire speculum (paediatric) 
6. Conjunctival forcep 
7. Surgical glove 
8. Surgical drape 
9. Shaver blade 
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10. Corneal scissors 
E. Laboratory instruments 
1. Centrifuge tube 
2. Repeat pipette tip 
3. Weighing scale machine 
4. Disposable biohazard bag 
 
2.5.10  Examiner 
 
   1. Primary Investigator 
2. Trainee Pathologist 
 
2.5.11 Study Procedures 
 
The study will be conducted after obtaining approval from the Animal 
Ethics Committee Universiti Sains Malaysia.  
 
A. Preparation of 10^
3
 CFU of Pseudomonas aeruginosa 
a. Pseudomonas aeruginosa (ATCC27853) will be grown overnight at 
37ºC in a trypticase soy agar (TSA).  
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b. The inoculum will be diluted with trypticase soy broth (TSB) to yield 
10^
3
 CFU/ml.  
 
B. Induction of Pseudomonas keratitis 
 
a. The rabbits will be anaesthetized by subcutaneous injection of a 
mixture of xylazine hydrochloride (100mg/ml) and ketamine 
hydrochloride (100mg/ml).  
b. Proparacaine hydrochloride will be applied to the rabbit‟s eye before 
intrastromal injection.  
c. Right cornea epithelium of each rabbit will be debride using 27G 
needle followed by intrastromal injection of 0.1ml (10^
3
 CFU/ml) 
Pseudomonas aeruginosa.  
d. Intramuscular buphrenorphine of 0.02-0.1mg/kg (every 6-12 hours) 
will be administered for pain relief.  
 
C. Preparation of 30% topical Tualang honey 
 
a. 100% Tualang honey will be given Gamma irradiation at a dose of 
25kGy followed by sterility test. 
b. Tualang honey will be diluted with water for injection until become 
30% (1.5ml water for injection + 3.5ml Tualang honey). 30% 
concentration is used due to its lowest concentration for bactericidal 
effect towards Pseudomonas aeruginosa is 25% (Tan et al., 2009). 
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D. Preparation of Manuka honey 
 
a. Manuka honey is manufactured by Melcare Biomedical Pty Ltd, 
Australia and available in the form of viscous eye drop with 
concentration of 98% Leptospermum scoparium. 
 
E. Instillation of topical eye drops 
 
a. Block randomization of 20 rabbits into two groups: Group A (n=10) 
and B (n=10). 
b. Topical eye drops will be instilled eight times per day after 24 hours.  
c. Group A will be started with topical Tualang honey 30% + topical 
gentamycin 0.3% 
d. Group B will be started with topical Manuka honey + topical 
gentamycin 0.3% 
 
F. Slit lamp examination score  
 
a. The rabbits will be examined at 24, 48, 72 hours, 5th and 7th days. 
b. The SLE score as below (Dong et al., 2012) 
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Table 1: Slit lamp examination score 
Grade                                                                             Focus of infection 
 
0            No focus of infection 
1            Corneal infiltrate         1.25                   Limited in the inoculated area 
                                                   1.50                   ≤ ½ corneal thickness 
                                                   1.75                   > ½ corneal thickness 
2            Corneal ulcer               2.25                   Diameter ≤ 3mm 
                                                   2.50                   > 3mm - < 5mm    
                                                   2.75                   Diameter ≥ 5mm 
3            Hypopyon                    3.25                   ≤ ⅓  
                                                   3.50                   ⅓ - ½  
                                                   3.75                   > ½ 
4            Hypopyon and corneal perforation                  
 
 
G. Cornea harvesting 
 
a. All rabbits will be euthanized by an intravenous injection of a 
pentobarbital sodium solution (100mg/ml) at Day 7.   
b. The entire cornea of right eye will be excised at the clear limbal 
margin, excluding any sclera or conjunctiva.  
c. The excised cornea will be rinsed with 5 ml of balanced salt solution, 
minced and placed in a test tube with 2 ml of phosphate buffered saline 
and homogenized.  
d. Aliquots of the cornea will be serially diluted and plate in TSA. 
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H. Colony Forming Unit count 
 
a. The TSA plates containing diluted aliquots of harvested cornea will be 
incubated for 18 hours at 37ºC.  
b. Colonies will be counted and mean Pseudomonas CFU will be 
determined.   
2.5.12 Statistical Analysis 
 
First Objective : To compare the mean SLE score between Tualang  
honey and Manuka honey as adjunctive treatment in Pseudomonas-induced  
keratitis at 24, 48, 72 hours, 5th day and 7th day. 
 
Table 1: The comparison of the mean SLE score between Tualang honey and  
Manuka honey as adjunctive treatment in Pseudomonas-induced keratitis.  
Time  Groups SLE score 
Mean (SD) 
Mean 
difference 
(95% CI) 
F-stat (df) P value 
24 hours A 
B 
    
48 hours A 
B 
    
72 hours A 
B 
    
Day 5 A 
B 
    
Day 7 A 
B 
    
Repeated measure ANOVA or Friedman test will be used for the statistical analysis 
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Second Objective : To compare the mean CFU count of Pseudomonas-induced  
keratitis followng treatment of Tualang and Manuka honey at Day 7. 
 
Table 2: The comparison of the mean CFU count of Pseudomonas-induced  
keratitis following treatment of Tualang honey and Manuka honey at Day 7. 
Treatment 
Group 
Colony Forming 
Unit (CFU) count 
Mean Difference 
(95% CI) 
F-stat (df) P value 
Mean (SD) 
Group A 
 
    
Group B 
 
    
 Independent t-test or Mann-Whitney test will be used for the statistical analysis 
 
2.5.13 Methods to minimize study errors 
 
A.  Serial clinical examination will be done by a primary investigator who 
is blinded. 
B.  Colony forming units count will be done by a trainee pathologist who 
is blinded. 
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2.5.14 Flow Chart 
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Young adult rabbit (n=20) 
Block randomization into 2 groups 
Group A (n=10) 
Topical Tualang honey 30% 
+ 
Topical Gentamycin 0.3% 
 
Group B (n=10) 
Topical Manuka honey  
+ 
        Topical Gentamycin 0.3% 
 
Serial clinical examination at 24, 48, 72 hours, 5th and 7th days 
Sacrifice under general anaesthesia and harvest the right cornea on day 7 
Intrastromal injection of right eye with 10^3 CFU of Pseudomonas aeruginosa 
1aaeaeruginosaaeroginosa  
Colony forming unit (CFU) counts from the cornea 
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